What direct-acting dopamine receptor agonist is recommended to be used in the treatments of

neuroleptic malignant syndrome (NMS) fo help lower the dopamine blockade?

A) benzotropine (Cogentin)

B) bromocriptine (Parlodel)

C) dantrolene (Dantrium)

D) trihexyphenidyl (Artane) - A) Bromocriptine (Parlodel) is the recommended direct acting

dopamine receptor agonist to help decrease the dopamine blockade. Danrolene (Dantrium) is a

muscle relaxant. Benzotropine (Cogentin) and Trihexyphenidyl (Ar...